These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5568579)

  • 1. [Effect of rifomycin on the dynamics of experimentally induced tuberculous lesions].
    Diaconitza G; Eskenasy A
    Acta Tuberc Pneumol Belg; 1971; 62(1):62-81. PubMed ID: 5568579
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rifampicin in experimental tuberculosis].
    Petrova MA; Berezina EK; Nabashin SM
    Antibiotiki; 1977 Jan; 22(1):64-8. PubMed ID: 843075
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacokinetics of rifomycin].
    Curci G; Ninni A; Iodice F
    Acta Tuberc Pneumol Belg; 1969; 60(3):276-87. PubMed ID: 5371665
    [No Abstract]   [Full Text] [Related]  

  • 4. [Intermittent rifomycin therapy of experimental tuberculosis in guinea pigs].
    Daddi G; Lucchesi M; Mancini P
    Ann Ist Carlo Forlanini; 1968; 28(4):354-68. PubMed ID: 5738472
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of rifampicin on experimental tuberculosis].
    Uvarova OA; Kozulitsyna TI; Korotaev GA
    Probl Tuberk; 1976 Jan; (l):65-70. PubMed ID: 995913
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antituberculous activity of rifampicin for the experimental tuberculosis of guinea pigs].
    Toyoara M
    Kekkaku; 1970 Nov; 45(11):375-8. PubMed ID: 5484188
    [No Abstract]   [Full Text] [Related]  

  • 7. [Microscopic changes in liver in experimental tuberculosis in guinea pigs treated with rifampicin].
    Westfal I; Zengteler G; Szymaczek-Meyer L
    Gruzlica; 1974 Sep; 42(9):879-85. PubMed ID: 4410147
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative histopathological studies of the results of continuous and intermittent treatment with rifampicin in experimental tuberculosis].
    Diaconiţă G; Luţescu L
    Ftiziologia; 1974 May; 23(3):269-80. PubMed ID: 4601851
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of rifomycin level in blood serum in tuberculous patients].
    Zwolska-Kwiek Z
    Gruzlica; 1971 Sep; 39(9):875-83. PubMed ID: 5111364
    [No Abstract]   [Full Text] [Related]  

  • 10. [Influence of treatment by ethionamide on the morphologic dynamics of experimental tuberculous inflammation].
    Diaconita G; Eskenasy A; Stoica E
    Poumon Coeur; 1965; 21(9):1115-24. PubMed ID: 5845716
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tuberculostatic activity of various rifampicin derivatives in vitro and in vivo].
    Kochanova NK; Miakotina EN; Bellendir EN; Boiarkina SK; Iudelevich VI
    Probl Tuberk; 1983 Jun; (6):65-8. PubMed ID: 6410375
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rifomycin levels in the lung and tuberculous lesions in man].
    Canetti G; Parrot R; Porven G; Le Lirzin M
    Acta Tuberc Pneumol Belg; 1969; 60(3):315-22. PubMed ID: 5371667
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use and activity of rifomycin in local treatment of extrapulmonary tubercular forms].
    Zanotelli F
    Fracastoro; 1965; 58(5):353-61. PubMed ID: 5854786
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental study of rifampicin and ethambutol].
    Kozulitsyna TI; Korotaev GA
    Probl Tuberk; 1971; 49(1):64-8. PubMed ID: 5576515
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antitubercular activity and pharmacokinetics of rifampicin].
    Ginzburg TS; Drabkina RO
    Antibiotiki; 1972 Jul; 17(7):607-11. PubMed ID: 4655011
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oxidative metabolism changes in respiratory tract cells of guinea pigs during natural development of experimental tuberculosis and under specific chemotherapy].
    Kaminskaia GO; Abdullaev RIu
    Probl Tuberk; 1996; (2):33-6. PubMed ID: 8657693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dynamics of the experimental tuberculous process under the influence of nerobol].
    Gomoliako IV; Bal'tseva LB; Klimenko MT
    Probl Tuberk; 1980 Jan; (1):60-3. PubMed ID: 7367427
    [No Abstract]   [Full Text] [Related]  

  • 18. Rifampicin: a new rifamycin. II. Laboratory studies on the antituberculous activity and preliminary clinical observations.
    Pallanza R; Arioli V; Furesz S; Bolzoni G
    Arzneimittelforschung; 1967 May; 17(5):529-34. PubMed ID: 5631580
    [No Abstract]   [Full Text] [Related]  

  • 19. Anatomo-histological effect of cycloserine on experimental tuberculosis lesions.
    Blasi A; Di Perna A
    Scand J Respir Dis Suppl; 1970; 71():68-75. PubMed ID: 4989523
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intermittent treatment with Rifampicin in experimental tuberculosis in guinea pigs].
    Nitti V; Ninni A; Marsico SA
    Arch Tisiol Mal Appar Respir; 1969 Dec; 24(12):923-43. PubMed ID: 5312739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.